Strengthening pharmacovigilance for herbal medicines in Nigeria: An urgent health systems challenge

Abstract

Get full access to this article

View all access options for this article.

References

Anthonia

. Nigerians resort to harmful alternatives as cost of drugs spike - businessday NG [Internet]. Businessday NG. 2024. Available from. https://businessday.ng/health/article/nigerians-resort-to-harmful-alternatives-as-cost-of-drugs-spike/

Esenwah

Ubiaru

Onianwah

FI,

et al. Review of the quality of herbal medicines marketed in Nigeria: regulatory challenges and microbiological safety issues. International Journal of Innovative Research and Advanced Studies (IJIRAS). 2025; 12(9): 14–15. https://www.ijiras.com/2025/Vol_12-Issue_9/paper_3.pdf, In this issue.

Balogun

Okon

Akanmu

, et al. Safety monitoring of herbal medicines in Nigeria: worrying state of pharmacovigilance system based on WHO core pharmacovigilance indicators. J Herbmed Pharmacol 2021; 10(2): 202–208. https://doi.org/10.34172/jhp.2021.22

Eruaga

Itua

Bature

. Regulatory oversight of herbal medicines: a NAFDAC case study. Int J Sci Res Arch 2024; 11(02): 207–211. https://doi.org/10.30574/ijsra.2024.11.2.0390

Bedu

. Quantitative and qualitative assessment of selected herbal remedies marketed in Nigeria. South American J Clin Res 2015; 2(1): 136–145.

Choi

Shin

H-K

. Adverse events associated with herbal medicine products reported in the Korea adverse event reporting system from 2012 to 2021. Front Pharmacol 2024; 15: 1378208. https://doi.org/10.3389/fphar.2024.1378208

National Agency for Food and Drug Administration and Control (NAFDAC) . Herbal medicines and related products (labelling) regulations. NAFDAC, 2005.